Glooko Inc. secured a $100 million series F financing to support expansion of its diabetes ecosystem platform, which ...

This was worse than our national election,” Eric Peterson said as he explained his vote Oct. 10 concluding that Stealth Biotherapeutics Inc.’s elamipretide is effective in treating Barth syndrome, an ...

Clostridioides difficile has been traditionally isolated from healthcare facilities' inpatients, but it is increasingly being identified in people who have not recently been hospitalized and is more ...

Purespring Therapeutics Ltd. has raised £80 million (US$104.6 million) in a series B, putting it on course to be the first to ...

Shiratronics Inc. raised $66 million in an oversubscribed series B financing round to support completion of its recently ...

It’s hard to know where to start in describing the biopharma applications of the 2024 Nobel Prize in Physics. It was awarded ...

The COVID-19 pandemic pushed the urgency for effective antiviral drugs against coronaviruses. Researchers from Europe ...

A digital cognitive assessment developed by Braincheck Inc., Braincheck Assess, proved comparable to the gold-standard ...

With confidence dropping in doing business with China-affiliated life sciences companies due to the Biosecure Act, one of the companies explicitly named in the U.S. legislation is fighting back.

GE Healthcare Technologies Inc. is participating in the €25.3 million (US$27.8 million) Thera4care project that aims to ...

Betta Pharmaceuticals Co. Ltd. has prepared and tested probable global transcription activator SNF2L2 (SMARCA2; BAF190B; SNF2-α) and transcription activator BRG1 (SMARCA4; BAF190A; SNF2-β) inhibitors ...

Cyclin-dependent kinases 12 and 13 (CDK12 and CDK13) are involved in the regulation of transcription elongation, DNA damage response and genomic stability balance. A few inhibitors of CDK12- and CDK13 ...